New Brunswick reports blood-clot death after Oxford AstraZeneca vaccine
Health & Safety COVID-19 New Brunswick Vaccine
FREDERICTON — New Brunswick health officials are reporting the province’s first death of someone who developed a blood clot after receiving the Oxford-AstraZeneca vaccine.
Chief medical officer of health Dr. Jennifer Russell says the individual in their 60s received the vaccine in mid-April and developed symptoms a week later.
She says the person was admitted to hospital and died two days later.
Russell told a news conference today the risk of complications from the vaccine remains very low, between one in 100,000 and one in 250,000 doses.
She says hundreds of thousands of doses of the AstraZeneca vaccine have been administered across Canada, the vast majority of them without incident.
The province has had two confirmed cases of the rare blood-clotting syndrome known as vaccine-induced thrombotic thrombocytopenia, or VITT.
Print this page